EJECTINE

Welcome to the Brand page for “EJECTINE”, which is offered here for Therapeutic drug for use in treating organ transplantation cancer and autoimmune disease;chemical preparation for use in immunological scientific research;.

Its status is currently believed to be active. Its class is unavailable. “EJECTINE” is believed to be currently owned by “SangStat Medical Corporation”.


Owner:
SANGSTAT MEDICAL CORPORATION
Owner Details
Description:
Therapeutic drug for use in treating organ transplantation cancer and autoimmune disease;chemical preparation for use in immunological scientific research;
Categories: THERAPEUTIC DRUG USE